Day: July 4, 2022

During the days 25 June – 1 July 2022 Marel hf. purchased 722,294 of its own shares on Nasdaq Iceland at the purchase price of ISK 447,775,256 and 62,545 of its own shares on Euronext Amsterdam at the purchase price of EUR 275,332. See further details in attachment and on Marel’s website: marel.com/buyback The trade is in accordance with Marel’s buyback programs on Nasdaq Iceland and Euronext Amsterdam, announced on 1 June 2022, which are based on the authorization of Marel hf.´s Annual General Meeting regarding the purchase of own shares on 16 March 2022. Marel hf. held 17,188,206 own shares prior to the notified transactions or the equivalent to 2.23% of issued shares in the company and held 17,973,045 own shares after the transactions, or the equivalent of 2.33% of issued shares in the company. Marel hf. has purchased a total of 4,000,000...

With integrated distribution, research, and commercialization capabilities following its acquisition of ADCO, the Company’s management is pleased to provide a detailed overview of its financial outlook, strategic priorities, and organizational alignment for the remainder of calendar 2022 as well as calendar 2023. At 4:15 pm Eastern (1:15 pm Pacific) on Wednesday, July 6, 2022, the Company will be hosting an information session via teleconference with CEO Michael Saxon and CFO Joel Dumaresq. Questions may be submitted in advance to TAAT® Investor Relations.Picture 1 In less than two years of retail availability, the Company has championed TAAT® as a category-creating alternative to tobacco cigarettes. In line with the business practices of “Big Tobacco” firms, the Company has incorporated the operations of a major Ohio tobacco distributor...

Company announcement no. 20/2022 Brian Iversen will take up the position as Chief Financial Officer (CFO) of Columbus. Brian Iversen joins from a position as Vice President of Group Finance in GN Store Nord. Columbus’ Board of Directors has appointed Brian Iversen as CFO and member of the Executive Board in Columbus. Brian Iversen will succeed Hans Henrik Thrane, who will leave Columbus 31 August 2022 as announced in release no. 19/2022 of 1 June 2022. Brian Iversen will join Columbus on 1 October 2022.    Brian is a senior executive with vast CFO experience and finance transformation and financial reporting experience from large international companies. He brings extensive experience in leading, optimizing and developing global finance operations, as well as implementing major strategic programs and improving business performance. Brian...

TORONTO, July 04, 2022 (GLOBE NEWSWIRE) — The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) herein announces the resignation of Maurice Levesque and Don Duet from the Board of Directors who are departing in order to pursue other opportunities. Flowr would like to thank Mr. Levesque and Mr. Duet for their service to the Company and wish them success in their future endeavours. About The Flowr Corporation The Flowr Corporation is a Canadian cannabis company with its operating campus, located in Kelowna, British Columbia. Flowr aims to support improving outcomes through responsible cannabis use and, as an established expert in cannabis cultivation, strives to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated...

NOT FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO U.S. NEWS WIRE SERVICES TORONTO, July 04, 2022 (GLOBE NEWSWIRE) — FAX Capital Corp. (TSX: FXC) (the “Company”) is pleased to announce that, pursuant to the previously announced plan of arrangement under the Canada Business Corporations Act (the “Arrangement”), Fax Investments Inc. (“Fax Investments”), acting through a wholly-owned acquisition company, has indirectly acquired all of the issued and outstanding subordinate voting shares of the Company (“Subordinate Voting Shares”), other than the Subordinate Voting Shares already owned by Fax Investments or Blair Driscoll, effective today for a price of $5.18 in cash per Subordinate Voting Share. A detailed description of the Arrangement, which was approved by the Company’s shareholders at its annual general and special...

VANCOUVER, Canada, July 04, 2022 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce that it has closed an oversubscribed, non-brokered private placement of 20,050,000 units (the “Unit”) at $0.15 per unit, for aggregate gross proceeds of $3,007,500 (the “Offering”). The Offering was initially announced on June 6, 2022, for up to 13,500,000 Units and increased on June 21, 2022, for up to 16,000,000 Units. Each Unit consists of one Sonoro Common Share and one Share Purchase Warrant. Each warrant entitles the holder to purchase one additional Sonoro Common Share for a period of two years from the closing date at an exercise price of $0.225 per share. All securities issued and issuable in connection with the Offering will be subject to a 4-month plus one day...

MONTREAL, July 04, 2022 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., is assuming full commercial activities and is relaunching AKYNZEO® (netupitant / palonosetron) in Brazil. On May 12, 2022 Knight and Helsinn Healthcare SA (“Helsinn”) announced they have entered into an exclusive license, distribution and supply agreement for oral/IV AKYNZEO® in Canada, Brazil, Argentina, Uruguay and Paraguay, and ALOXI® oral/IV (palonosetron) in Canada (the “Products”). AKYNZEO® is approved for the prevention of chemotherapy-induced acute and delayed nausea and vomiting. According to IQVIA, sales of AKYNZEO® in Canada and Brazil were approximately $7 million in 2021. “We...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CareTech Holdings plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position...